Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/21/2010 | CA2451909C High throughput assays for the proteolytic activities of clostridial neurotoxins |
12/21/2010 | CA2420771C Enhanced transfection system |
12/21/2010 | CA2412004C Glucagon-like peptide-1 analogs |
12/21/2010 | CA2387182C Lentiviral vectors for the preparation of immunotherapeutical compositions |
12/21/2010 | CA2368802C Mutations associated with iron disorders |
12/21/2010 | CA2341636C Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity |
12/21/2010 | CA2329138C Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
12/21/2010 | CA2307316C Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
12/21/2010 | CA2270281C Method to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens |
12/21/2010 | CA2267069C Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
12/21/2010 | CA2264255C Disruption of the cytochrome c gene in xylose-fermenting yeast |
12/21/2010 | CA2260273C Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies |
12/21/2010 | CA2223833C Compounds and peptides that bind to the erythropoietin receptor |
12/21/2010 | CA2220753C Novel peptides and compositions which modulate apoptosis |
12/21/2010 | CA2199821C Cloning and regulation of an endothelial cell protein c/activated protein c receptor |
12/16/2010 | WO2010144794A1 Baculovirus-expressed fusion polypeptide vaccines with enhanced immunogenicity and uses thereof |
12/16/2010 | WO2010144711A2 Immunological targeting of pathological tau proteins |
12/16/2010 | WO2010144678A2 Generation of vascularized human heart tissue and uses thereof |
12/16/2010 | WO2010144502A2 Growth hormone polypeptides and methods of making and using same |
12/16/2010 | WO2010144452A1 Methods for increasing thermogenic adipocytes |
12/16/2010 | WO2010144283A1 Bacillus strain for increased protein production |
12/16/2010 | WO2010144231A2 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
12/16/2010 | WO2010143708A1 Targeting agent for neovascularization |
12/16/2010 | WO2010143539A1 Antifreeze substance |
12/16/2010 | WO2010143435A1 Vaccine therapy for choroidal neovascularization |
12/16/2010 | WO2010143194A1 Stable immunogenic protein having multiple cysteines molecules process therefor and composition thereof |
12/16/2010 | WO2010143010A1 Identification, optimization and use of shared hla-b*0702 epitopes for immunotherapy |
12/16/2010 | WO2010142981A2 Composition and uses thereof |
12/16/2010 | WO2010142906A2 Protein antigens for the serodiagnosis of staphylococcus aureus infections, in particular on osteoarticular prostheses |
12/16/2010 | WO2010142850A1 Hydrophobins for dispersing active agents |
12/16/2010 | WO2010142041A1 Serine rich peptides having antioxidative stress properties |
12/16/2010 | WO2010142040A1 Novel netrin derivatives and uses thereof |
12/16/2010 | WO2010142035A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system |
12/16/2010 | WO2010141985A1 Methods of treatment |
12/16/2010 | WO2010120511A3 Method of treating respiratory disorders |
12/16/2010 | WO2010107560A3 Fungal cutinase from magnaporthe grisea |
12/16/2010 | WO2010093784A3 Modified virus vectors and methods of making and using the same |
12/16/2010 | WO2010089756A3 An improved process for pegylation of proteins |
12/16/2010 | WO2010041241A3 Hiv-1 integrase derived stimulatory peptides interfering with integrase - rev protein binding |
12/16/2010 | WO2007146689A9 Stabilized insulin-like growth factor polypeptides |
12/16/2010 | US20100319093 Dig-11 insecticidal cry toxins |
12/16/2010 | US20100319092 Dig-10 insecticidal cry toxins |
12/16/2010 | US20100319088 Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same |
12/16/2010 | US20100319087 Methods for Transforming Plants to Express Delta-Endotoxins |
12/16/2010 | US20100319086 Leafy cotyledon 1 transcriptional activator (lec1) variant polynucleotides and polypeptides, compositions and methods of increasing oil content in plants |
12/16/2010 | US20100319083 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom |
12/16/2010 | US20100319076 Transgenic non-human animals for pharmacological and toxicological studies |
12/16/2010 | US20100317833 Method for the production of dry free-flowing hydrophobin preparations |
12/16/2010 | US20100317830 Bace455, an alternative splice variant of the human beta-secretase |
12/16/2010 | US20100317827 Method of Purifying a Peptide |
12/16/2010 | US20100317826 Neoplasm specific antibodies and uses thereof |
12/16/2010 | US20100317610 Methods and Compositions for Inducing Deregulation of EPHA7 and ERK Phosphorylation in Human Acute Leukemias |
12/16/2010 | US20100317609 Method of Producing Hydroxyalkyl Starch Derivatives |
12/16/2010 | US20100317601 Casein Derived Peptides And Uses Thereof |
12/16/2010 | US20100317600 Process for Preparing Cardiodilatin Fragments; Highly Purified Cardiodilatin Fragments and Intermediate Products for the Preparation of Same |
12/16/2010 | US20100317599 Process for the production of a peptide |
12/16/2010 | US20100317598 Isolated BRCA1 Peptides and Method of Use |
12/16/2010 | US20100317594 Methods for treating breast cancer using NRIF3 related molecules |
12/16/2010 | US20100317592 Chemokine-binding protein and methods of use |
12/16/2010 | US20100317588 Compositions comprising fibrous polypeptides and polysaccharides |
12/16/2010 | US20100317585 Long-acting coagulation factors and methods of producing same |
12/16/2010 | US20100317577 Methods and Compositions for Inhibiting Cell Death or Enhacing Cell Proliferation |
12/16/2010 | US20100317570 Composition and Method for the Treatment of Diseases Affected by a Peptide Receptor |
12/16/2010 | US20100317569 Dig-5 insecticidal cry toxins |
12/16/2010 | US20100317566 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
12/16/2010 | US20100317565 Novel Peptides and Their Use for the Treatment of Edema |
12/16/2010 | US20100317564 Immunoregulatory peptides and methods of use |
12/16/2010 | US20100317536 Crystal structure of human gpvi and applications thereof |
12/16/2010 | US20100317119 Quenched Fluorophores Conjugated to Peptides Via Linkers Containing Dithio Groups |
12/16/2010 | US20100317082 Related ribonucleases in which an amino acid sequence of a known ribonuclease is preceded by at least one residue at the n-terminus, and methods of making them recombinantly |
12/16/2010 | US20100317081 Counter-Pressure Filtration of Proteins |
12/16/2010 | US20100317054 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF |
12/16/2010 | US20100317050 Polypeptides for microbial detection |
12/16/2010 | US20100317046 Non-Endogenous, Constitutively Activated Versions of Human G Protein Coupled Receptor: FSHR |
12/16/2010 | US20100317042 Proteins activating pro-phenoloxidase system and genes encoding the same |
12/16/2010 | US20100317036 Mycobacterium Antigens |
12/16/2010 | US20100317034 Primate t-lymphotropic viruses |
12/16/2010 | US20100317026 VMP-Like Sequences Of Pathogenic Borrelia |
12/16/2010 | US20100317013 Methods and compositions for detecting spermatozoa or semen in a sample |
12/16/2010 | US20100317011 Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use |
12/16/2010 | US20100317010 ELF3 gene compositions and methods |
12/16/2010 | US20100317003 Novel compositions and methods in cancer with altered expression of kcnj9 |
12/16/2010 | US20100316996 Nasopharyngeal cancer malignancy biomarker and method thereof |
12/16/2010 | US20100316994 Diagnosis and therapy of cancer using sgp28-related molecules |
12/16/2010 | US20100316707 Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells |
12/16/2010 | US20100316702 Compositions and methods for regulating erythropoeitin expression and ameliorating anemia and stimulating erythropoiesis |
12/16/2010 | US20100316698 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
12/16/2010 | US20100316675 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
12/16/2010 | US20100316672 Vaccine |
12/16/2010 | US20100316670 Chimeric sle/dengue type 4 antigenic viruses |
12/16/2010 | US20100316666 Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition |
12/16/2010 | US20100316665 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
12/16/2010 | US20100316661 HIV-1 Envelope Glycoprotein Oligomer and Methods of Use |
12/16/2010 | US20100316650 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions |
12/16/2010 | US20100316648 Novel plasminogen receptor, polypeptides and antibodies thereof |
12/16/2010 | US20100316647 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy |
12/16/2010 | US20100316644 Truncated actriib-fc fusion proteins |
12/16/2010 | US20100316643 Targeted antimicrobial moieties |
12/16/2010 | US20100316621 Prophylatic agent for autoimmune disease |
12/16/2010 | US20100316616 Use of FZC18-Containing Collagen 18 Polypeptides for the Treatment, Diagnosis and Outcome Prediction of Diseases |